Помалидомид - analogs
Components: Pomalidomide |
|||||||||
Pharmgroups: Immunosuppressants |
|||||||||
Prices in pharmacies: — Instructions Помалидомид | |||||||||
|
ⓘ✘Enter drugs for проверки взаимодействовий through a quick button search . Элмапарин ✘ (incl) K-Dur ✘ (incl) Левоцетиризин Реневал ✘ (incl) Padi avii fructus ✘ (incl) Xymelin Extra ✘ (incl) Bleomycin sulfate ✘ (incl) Listab 75 ✘ (incl) Cardio Complex ✘ (incl) Sanocef ✘ (incl) Calcium D-pantothenate ✘ (incl) Levofloxacin ✘ (incl) Flowers Energy №21 ✘ (incl) Nasobec ✘ (incl) Винпоцетин-Акрихин ✘ (incl) Bisoprolol fumarate ✘ |
|
ⓘ✘ diseases to evaluate contraindications and side effects through a quick search. |
Начиная работу с сервисом, вы принимаете соглашение пользователя. Kiberis do not replace the doctor!
Similar | Complete analog ⓘ✘Аналоги препарата с полностью совпадающими действующими веществами |
Prices in pharmacies |
≈100% | Imnovid neutral | 6352.5-6726.4€ |
≈100% | Pomalidomide-TL neutral | — |
-
Similar
Prices in
pharmaciesAnalogs by action ⓘ✘Analogues of the drug according to its degree of similarity with other drugs that are not direct analogues
- 45% 194.3-777.1€ Darzalex Negative 🔍 [Daratumumab]
- 42% 788.9€ Kyprolis neutral [Carfilzomib]
- 34% 2417.8€ Ninlaro neutral [Ixazomib]
- 34% — Иксазомиба цитрат neutral [Ixazomib]
- 31% 1381.2€ Empliciti Negative 🔍 [Elotuzumab]
- 26% — Тироджин neutral [Thyrotropin alfa]
- 25% — Сарклиза Negative 🔍 [Isatuximab]
- 25% 992.7€ Talcenna neutral [Talazoparib]
- 24% — Леноалромид neutral [Lenalidomide]
- 24% — Lenalidomide Canon neutral [Lenalidomide]
- 23% 220.5-642.6€ Ixempra neutral [Ixabepilone]
- 23% 1920€ Tasigna neutral [Nilotinib]
- 23% 807.2-809.8€ Итулси neutral [Palbociclib]
- 23% 73.5€ Onicit neutral [Palonosetron]
- 23% — Nilotinib hydrochloride monohydrate neutral [Nilotinib]
- 23% — Nilotinib-nativ neutral [Nilotinib]
- 23% 798-825€ Ibrance neutral [Palbociclib]
- 23% — Нилотиниб neutral [Nilotinib]
- 21% 324.5€ Иглиб Negative 🔍 [Imatinib]
- 21% — Imatinib medac Negative 🔍 [Imatinib]
- 21% 1296.2-2074.1€ Kadcyla Negative 🔍 [Trastuzumab emtansine]
- 21% — Citonib Negative 🔍 [Imatinib]
- 21% — Gistamel Negative 🔍 [Imatinib]
- 21% — Imagliv Negative 🔍 [Imatinib]
- 21% — Iimatinib mesilate Negative 🔍 [Imatinib]
- 21% — Imatinib-Alvogen Negative 🔍 [Imatinib]
- 21% — Imatinib-Actavis Negative 🔍 [Imatinib]
- 21% — Бонспри Negative 🔍 [Ofatumumab]
- 20% — Бортезомиб Канон neutral [Bortezomib]
- 20% — Uro-BCG-medac neutral [Vaccinum for immunotherape cancer of vesica urinaria]
- 20% — ANDRAXAN neutral
- 20% 77-80.5€ Femara neutral [Letrozole]
- 20% 296€ Halaven neutral [Eribulin]
- 20% 104.5€ Велмиб3.5 neutral [Bortezomib]
- 20% — Милатиб neutral [Bortezomib]
- 20% — Майборте neutral [Bortezomib]
- 18% 1328€ Revlimid neutral [Lenalidomide]
- 18% 3936.6€ Кабометикс neutral [Cabozantinib]
- 17% 136.3€ Бартизар neutral [Bortezomib]
- 17% — Verozomib neutral [Bortezomib]
- 17% — Proleukin neutral [Aldesleukin]
- 17% — Bortezol neutral [Bortezomib]
- 17% — Lenalidomide neutral [Lenalidomide]
- 17% — БОРАТЕРИН neutral [Bortezomib]
- 17% 140-149.4€ Velcade neutral [Bortezomib]
- 17% — Egistrazol Negative 🔍 [Anastrozole]
- 17% 29.8€ Imuron-vac neutral [Vaccinum for immunotherape cancer of vesica urinaria]
- 17% — Ленанжио neutral [Lenalidomide]
- 17% — Эверолимус-промомед neutral [Everolimus]
- 16% — Ковада Negative 🔍 [Bendamustine]
Learn more about the selection of analogues
- The drug has «Помалидомид» 3 full analogs, the cheapest - Imnovid (6352.5-6726.4€); 51 analog by action, the most similar - Darzalex (194.3-777.1€).
- Medical online service has selected the best substitutes for Помалидомид based on its instructions, components, pharmaceutical groups and practical application.
- The table shows the prices of Помалидомид analogues to choose the cheapest pills.
- If you have introduced other drugs for registration, substitutes are selected taking into account the assessment of interactions and safety.
- Sometimes, due to the presence of dangerous interactions, it is necessary to use drugs that are similar in effect, sometimes even from different pharmacological groups.